Search "apigenin testosterone" and you'll find confident claims that apigenin is a natural testosterone booster, usually citing some combination of CD38 inhibition, aromatase inhibition, and a mouse Leydig cell study. Each of those citations is real. None of them is a human trial showing that taking apigenin raises testosterone. This article separates the three distinct mechanisms being cited, explains what each one actually demonstrated, and is explicit about where the evidence stops.
Key Takeaways
- Three separate mechanisms get cited as "apigenin boosts testosterone": CD38/NAD+ inhibition, aromatase inhibition, and direct StAR gene upregulation in mouse Leydig cells. They are not the same claim and have different levels of support.
- CD38 inhibition raising NAD+ is well-documented in obese mice, but that study never measured testosterone—the T connection is inferred, not shown.
- Aromatase inhibition is a real in-vitro effect, but apigenin is a comparatively weak inhibitor next to chrysin, and blocking conversion of testosterone to estrogen is not the same mechanism as increasing testosterone synthesis.
- The most direct evidence—apigenin enhancing steroid output in isolated mouse Leydig cells—is a real, interesting finding, but it is a cell-culture result in aging rodent tissue, not a human dose-response study.
- No published human trial has measured apigenin's effect on serum testosterone. Every claim you see about "raising T" is extrapolated from mechanisms, not measured in people.
Three Different Claims Being Conflated
When people say "apigenin boosts testosterone," they are usually pointing to one of three separate lines of research that get blended together in supplement marketing:
1. Apigenin inhibits CD38, an enzyme that consumes NAD+, and higher NAD+ is loosely associated with better mitochondrial and metabolic function, including in steroid-producing tissue.
2. Apigenin inhibits aromatase, the enzyme that converts testosterone into estrogen, which in theory could leave more testosterone unconverted.
3. Apigenin directly increased steroid hormone output in isolated mouse Leydig cells by boosting a specific regulatory protein.
These are mechanistically distinct pathways with different bodies of evidence behind them. Treating them as one unified "apigenin raises T" story overstates what any single study actually showed.
CD38 Inhibition and NAD+: Real Effect, Unmeasured Endpoint
The foundational study here is a 2013 paper that identified apigenin (alongside quercetin) as an inhibitor of CD38, a cell-surface enzyme that degrades NAD+.[1] In that study, apigenin treatment increased NAD+ levels in obese mice, reduced global protein acetylation, and improved several markers of glucose and lipid metabolism. This is a legitimate, well-cited mechanistic finding in metabolic research.
What the study did not do is measure testosterone, Leydig cell function, or any hormonal endpoint. NAD+ availability is broadly important for mitochondrial function, and steroidogenesis is mitochondria-dependent, so a chain of reasoning connects "more NAD+" to "better steroidogenic capacity." But that chain has multiple unverified links. No study has taken this specific mechanism and tested whether it changes circulating testosterone in an intact animal, let alone a human.
Aromatase Inhibition: A Mechanism That Cuts Both Ways
Apigenin's aromatase-inhibiting activity is one of the older, more established findings in the flavonoid literature. A 1984 study using human placental and ovarian microsomes found that several flavones—including chrysin, apigenin, flavone, and quercetin—inhibited aromatase, the enzyme that converts androstenedione and testosterone into estrogens.[2] In that cell-free system, apigenin ranked behind chrysin in potency, with an IC50 in the low single-digit micromolar range.
The logic behind the testosterone claim is straightforward: if less testosterone gets converted to estrogen, more stays as testosterone. But this reasoning has two problems. First, aromatase inhibition does not increase testosterone synthesis—it changes what happens to testosterone that has already been made, which is a different mechanism than the CD38 or Leydig cell pathways above. Second, the micromolar concentrations that showed inhibition in isolated microsomes are far higher than what is plausible from an oral apigenin dose, given the compound's poor oral bioavailability (commonly reported in the low single digits to roughly 30% relative bioavailability in rat pharmacokinetic studies, depending on formulation). Whether a standard 50 mg capsule gets anywhere near tissue concentrations that meaningfully inhibit aromatase in a living person has not been tested.
Direct Evidence From Mouse Leydig Cells
The most direct pro-steroidogenic evidence comes from a 2011 study that treated isolated mouse Leydig cells with apigenin and measured steroid hormone output directly.[3] The researchers were specifically interested in age-related testosterone decline, which is associated with reduced expression of StAR (steroidogenic acute regulatory protein), the protein that controls the rate-limiting step of testosterone synthesis.
Apigenin enhanced cAMP-stimulated StAR gene expression and increased steroid hormone production in these cells. The proposed mechanism involved apigenin blocking a signaling pathway (COX-2/thromboxane A2 receptor) that normally suppresses StAR sensitivity in aging Leydig cells. This is a genuinely interesting, mechanistically specific finding—and it is the closest any of the three lines of research comes to demonstrating a direct pro-testosterone effect.
The limitations are still significant. This was isolated mouse Leydig cells in culture, treated with apigenin directly at a set concentration, not an oral dose delivered to a living animal with a functioning gut, liver, and bloodstream in between. Whether an oral apigenin supplement reaches Leydig cells at a comparable concentration in vivo, in mice or in humans, has not been established.
What Human Data Actually Exists
None, specific to testosterone. There is no published human trial that has given people apigenin and measured serum testosterone, free testosterone, or any downstream androgen marker as an outcome. The claims circulating in fitness and biohacking spaces are built entirely by connecting three separate preclinical mechanisms into a single narrative that no study has actually tested end to end.
This does not mean the mechanisms are fake or the research direction is uninteresting—CD38/NAD+ biology and Leydig cell steroidogenic sensitivity are both active, legitimate research areas. It means the specific claim "apigenin raises testosterone in humans" is currently unsupported by direct evidence, however plausible it sounds when you stack three preclinical findings on top of each other.
Bottom Line
If you are taking apigenin for sleep or its GABA-A activity and find the testosterone mechanisms interesting, that is reasonable—the underlying cell biology is real and published in peer-reviewed journals. But treat "apigenin as a testosterone booster" as a hypothesis built from indirect evidence, not a demonstrated effect. Anyone specifically supplementing for hormonal reasons should get baseline labs, talk to a physician, and understand that the human evidence for this particular claim does not yet exist.
References
- Escande C et al. Flavonoid apigenin is an inhibitor of the NAD+ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes (2013). PMID 23172919
- Kellis JT Jr, Vickery LE. Inhibition of human estrogen synthetase (aromatase) by flavones. Science (1984). PMID 6474163
- Li X et al. Effects of apigenin on steroidogenesis and steroidogenic acute regulatory gene expression in mouse Leydig cells. Journal of Nutritional Biochemistry (2011). PMID 20537519
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
